Apcotex Industries Ltd

- The company raised term loan debt of about INR 125 crore recently to fund the capital expenditure of around INR 200 crore. - Current debt level increased compared to March due to this term loan and working capital needs. - The company is comfortable with the current debt level and has about INR 100 crore cash on the books for potential opportunities. - No major decisions have been taken on future large CAPEX or debt raising as of now. - Focus is on managing balance sheet comfortably before any new major investments. - Maintenance CAPEX only planned for the near future; no new equity fundraising mentioned. - Future major CAPEX like NBR second line (15,000 tons) is on hold due to market uncertainties and balance sheet considerations.

- The company has completed major recent CAPEX of about ₹200 crore, including the Valia capacity (₹150-160 crore) and Taloja multipurpose latex plant (around ₹50 crore). - No new major CAPEX decisions have been taken currently; focus is on maintenance CAPEX only. - A potential future CAPEX plan involves adding a second NBR line with 15,000 tonnes capacity, but this is on hold awaiting clearer market conditions and to maintain balance sheet comfort. - The company is holding off on large investments, monitoring uncertainties like EV impact on NBR demand and market margins. - Some R&D investment is ongoing for new products in SBR latex with potential to boost turnover but will require further capital only when balance sheet permits. - Overall, future CAPEX is expected to be modest for now, with major plans deferred until market clarity improves.

- The company aims to fully utilize plant capacities within the next three years, implying steady volume growth (Page 5). - Volume growth is expected primarily from nitrile latex for gloves, especially in export markets such as Southeast Asia (Pages 6, 13, 17). - Export volumes have shown strong growth (around 120% year-on-year), while domestic volumes have grown modestly at 7-8% (Pages 4, 16, 17). - CAPEX plans are limited to maintenance currently; a new 15,000-tonne NBR line is designed but on hold due to market uncertainties (Page 6). - Margins in nitrile latex have compressed due to oversupply and low demand despite higher volumes, but they hope for recovery in the second half (Pages 5, 7, 11, 17). - Long-term growth also hinges on structural recovery of the glove industry and higher margins in glove-related nitrile latex business (Page 17).

- The company aims to finish current expenditures by 2024-25 and target profit margins above 10%. - They expect to utilize plant capacities fully within three years, indicating volume growth, although they do not provide explicit volume guidance. - Despite strong volume growth, margins have been pressured, especially in nitrile latex gloves due to low current margins near breakeven. Margin recovery depends on the glove business reaching double-digit margins again. - There is optimism that margins in nitrile latex will improve as market supply-demand balances out in the next several quarters, though timing is uncertain. - Overall company EBITDA margins are expected to recover or improve once glove business margins improve and new plants reach higher utilization. - Future growth will be supported by export volume growth, new product development in latex chemistries, and controlled capex maintaining balance sheet health. - NBR segment growth is cautious due to EV transition uncertainty but remains generally bullish for the long term.

The transcript on page 17 of the provided document does not mention any details about the current or expected order book or pending orders. The discussion focuses mainly on: - Quarter-on-quarter run rate increases (from 14 crore to 17.5 crore). - Increment cycles completing by June. - Hiring mainly for a new plant, with limited plans for further significant hiring. - Structural margin profile regarding the glove business and other business segments. - Challenges related to glove business margins and the need for industry recovery to achieve a 15% margin profile. No specific figures or commentary on order book or pending orders are provided in this section.